93 related articles for article (PubMed ID: 36605381)
21. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.
Tanimoto S; Itoh SG; Okumura H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142270
[TBL] [Abstract][Full Text] [Related]
22. A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
Zhong M; Sun A; Xiao T; Yao G; Sang L; Zheng X; Zhang J; Jin X; Xu L; Yang W; Wang P; Hu K; Zhang D; Ge J
Front Med (Lausanne); 2021; 8():566609. PubMed ID: 35186959
[TBL] [Abstract][Full Text] [Related]
23. C
Hurmach VV; Platonov MO; Prylutska SV; Scharff P; Prylutskyy YI; Ritter U
Sci Rep; 2021 Sep; 11(1):17748. PubMed ID: 34493768
[TBL] [Abstract][Full Text] [Related]
24. RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2.
Mishra A; Rathore AS
J Biomol Struct Dyn; 2022 Aug; 40(13):6039-6051. PubMed ID: 33491569
[TBL] [Abstract][Full Text] [Related]
25. Looking beyond COVID-19 vaccine phase 3 trials.
Kim JH; Marks F; Clemens JD
Nat Med; 2021 Feb; 27(2):205-211. PubMed ID: 33469205
[TBL] [Abstract][Full Text] [Related]
26. Meta-MUMS COVID-19 web server: an online daily monitoring server for comparative and cumulative epidemiological analysis.
Sokouti M; Sadeghi R; Pashazadeh S; Eslami S; Sokouti M; Ghojazadeh M; Sokouti B
Z Gesundh Wiss; 2023; 31(1):37-39. PubMed ID: 33457187
[No Abstract] [Full Text] [Related]
27. Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review.
Andrade BS; Rangel FS; Santos NO; Freitas ADS; Soares WRA; Siqueira S; Barh D; Góes-Neto A; Birbrair A; Azevedo VAC
Front Pharmacol; 2020; 11():590598. PubMed ID: 33390967
[TBL] [Abstract][Full Text] [Related]
28. SARS coronavirus 2: from genome to infectome.
Rastogi M; Pandey N; Shukla A; Singh SK
Respir Res; 2020 Dec; 21(1):318. PubMed ID: 33261606
[TBL] [Abstract][Full Text] [Related]
29. Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses.
Joshi A; Sunil Krishnan G; Kaushik V
J Genet Eng Biotechnol; 2020 Nov; 18(1):78. PubMed ID: 33245459
[TBL] [Abstract][Full Text] [Related]
30. Challenges for Drug Repurposing in the COVID-19 Pandemic Era.
Sultana J; Crisafulli S; Gabbay F; Lynn E; Shakir S; Trifirò G
Front Pharmacol; 2020; 11():588654. PubMed ID: 33240091
[TBL] [Abstract][Full Text] [Related]
31. Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
F1000Res; 2020; 9():1166. PubMed ID: 33204411
[No Abstract] [Full Text] [Related]
32. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
[TBL] [Abstract][Full Text] [Related]
33. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
34. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
Anderson EJ; Rouphael NG; Widge AT; Jackson LA; Roberts PC; Makhene M; Chappell JD; Denison MR; Stevens LJ; Pruijssers AJ; McDermott AB; Flach B; Lin BC; Doria-Rose NA; O'Dell S; Schmidt SD; Corbett KS; Swanson PA; Padilla M; Neuzil KM; Bennett H; Leav B; Makowski M; Albert J; Cross K; Edara VV; Floyd K; Suthar MS; Martinez DR; Baric R; Buchanan W; Luke CJ; Phadke VK; Rostad CA; Ledgerwood JE; Graham BS; Beigel JH;
N Engl J Med; 2020 Dec; 383(25):2427-2438. PubMed ID: 32991794
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.
Zhang XL; Li ZM; Ye JT; Lu J; Ye LL; Zhang CX; Liu PQ; Duan DD
Acta Pharmacol Sin; 2020 Nov; 41(11):1377-1386. PubMed ID: 32968208
[TBL] [Abstract][Full Text] [Related]
36. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
37. The coronavirus is mutating - does it matter?
Callaway E
Nature; 2020 Sep; 585(7824):174-177. PubMed ID: 32901123
[No Abstract] [Full Text] [Related]
38. Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy.
Piyush R; Rajarshi K; Khan R; Ray S
Open Biol; 2020 Sep; 10(9):200174. PubMed ID: 32898468
[TBL] [Abstract][Full Text] [Related]
39. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Logunov DY; Dolzhikova IV; Zubkova OV; Tukhvatullin AI; Shcheblyakov DV; Dzharullaeva AS; Grousova DM; Erokhova AS; Kovyrshina AV; Botikov AG; Izhaeva FM; Popova O; Ozharovskaya TA; Esmagambetov IB; Favorskaya IA; Zrelkin DI; Voronina DV; Shcherbinin DN; Semikhin AS; Simakova YV; Tokarskaya EA; Lubenets NL; Egorova DA; Shmarov MM; Nikitenko NA; Morozova LF; Smolyarchuk EA; Kryukov EV; Babira VF; Borisevich SV; Naroditsky BS; Gintsburg AL
Lancet; 2020 Sep; 396(10255):887-897. PubMed ID: 32896291
[TBL] [Abstract][Full Text] [Related]
40. Remdesivir: First Approval.
Lamb YN
Drugs; 2020 Sep; 80(13):1355-1363. PubMed ID: 32870481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
